Cash flow Laboratorios Farmaceuticos Rovi, S.A.

Stocks

ROVI

ES0157261019

Pharmaceuticals

Market Closed - BME Other stock markets 11:37:44 2026-07-31 am EDT			After hours 01:27:04 pm
58.55 ^EUR	-1.18%		58.72	+0.30%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

b0fcf482ceff5eb64b6e3.dFx5q2MJNH7rIqPNMdqKZRrWe0PFh-z0H1oKPI9KoGA.Exk9kiY_fy6FY_Wec4--DyOOSzuzw7uNfQ5abfYf9C0MHgvMLURBE9l15g

Published financial data: LABORATORIOS FARMACEUTICOS ROVI, S.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	649M	818M	830M	764M	743M
Total Revenues	649M	818M	830M	764M	743M
Cost of Goods Sold, Total	269M	305M	346M	296M	272M
Gross Profit	380M	512M	483M	468M	472M
Selling General & Admin Expenses, Total	103M	130M	147M	158M	160M
Depreciation & Amortization - (IS)	21.36M	22.87M	24.33M	28.02M	30.37M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	73.44M	106M	92.52M	103M	108M
Other Operating Expenses, Total	198M	259M	264M	289M	298M
Operating Income	182M	254M	219M	179M	173M
Interest Expense, Total	-905K	-849K	-948K	-2.35M	-2.56M
Interest And Investment Income	68K	6K	7K	26K	505K
Net Interest Expenses	-837K	-843K	-941K	-2.32M	-2.06M
Income (Loss) On Equity Invest.	182K	199K	-125K	-141K	60K
Currency Exchange Gains (Loss)	-178K	-821K	-86K	296K	-214K
Other Non Operating Income (Expenses)	3.4M	3.93M	2.09M	1.15M	12.33M
EBT, Excl. Unusual Items	184M	256M	220M	178M	183M
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	1.76M	-	-	-
Asset Writedown	-95K	-2K	-	-	-
Other Unusual Items	-1.58M	-	-	-	-
EBT, Incl. Unusual Items	183M	258M	220M	178M	183M
Income Tax Expense	29.55M	58.3M	50.11M	40.81M	42.9M
Earnings From Continuing Operations	153M	200M	170M	137M	140M
Net Income to Company	153M	200M	170M	137M	140M
Minority Interest	-	4K	36K	5K	78K
Net Income - (IS)	153M	200M	170M	137M	140M
Net Income to Common Incl Extra Items	153M	200M	170M	137M	140M
Net Income to Common Excl. Extra Items	153M	200M	170M	137M	140M
Per Share Items
Net EPS - Basic	2.76	3.73	3.2	2.67	2.75
Basic EPS - Continuing Operations	2.76	3.73	3.2	2.67	2.75
Basic Weighted Average Shares Outstanding	55.4M	53.47M	53.19M	51.21M	51.15M
Net EPS - Diluted	2.76	3.73	3.2	2.67	2.75
Diluted EPS - Continuing Operations	2.76	3.73	3.2	2.67	2.75
Diluted Weighted Average Shares Outstanding	55.4M	53.47M	53.19M	51.21M	51.15M
Normalized Basic EPS	2.08	3	2.59	2.17	2.24
Normalized Diluted EPS	2.08	3	2.59	2.17	2.24
Dividend Per Share	0.96	1.29	1.1	0.94	0.96
Payout Ratio	13.8	25.55	40.54	41.24	34.06
Supplemental Items
EBITDA	198M	271M	238M	200M	196M
EBITA	184M	256M	222M	181M	175M
EBIT	182M	254M	219M	179M	173M
EBITDAR	199M	275M	240M	200M	197M
Effective Tax Rate - (Ratio)	16.18	22.6	22.73	22.97	23.41
Total Current Taxes	21.94M	57.47M	50.83M	42.79M	44.56M
Total Deferred Taxes	7.1M	1.27M	-64K	-1.07M	-1.11M
Normalized Net Income	115M	160M	138M	111M	115M
Interest on Long-Term Debt	-	243K	281K	362K	282K
Non-Cash Pension Expense	813K	758K	793K	1.58M	1.12M
Supplemental Operating Expense Items
Advertising Expense	12.71M	19.99M	21.75M	21.74M	18M
Selling and Marketing Expenses	12.71M	19.99M	21.75M	21.74M	18M
Research And Development Expense From Footnotes	27.9M	24.31M	25.36M	26.19M	38.24M
Net Rental Expense, Total	839K	3.47M	2.46M	860K	1.38M
Imputed Operating Lease Interest Expense	82.3K	324K	271K	180K	240K
Imputed Operating Lease Depreciation	757K	3.15M	2.19M	680K	1.14M
Maintenance & Repair Expenses, Total	4.99M	7.18M	8.94M	10.64M	11.1M
Stock-Based Comp., SG&A Exp. (Total)	2.52M	-	-	-	-
Total Stock-Based Compensation	2.52M	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	99.04M	125M	25.32M	27.19M	97.98M
Short Term Investments	100K	89K	113K	830K	621K
Total Cash And Short Term Investments	99.14M	125M	25.44M	28.02M	98.6M
Accounts Receivable, Total	130M	160M	125M	115M	163M
Other Receivables	27.83M	21.06M	15.91M	12.61M	12.04M
Total Receivables	158M	181M	140M	127M	175M
Inventory	245M	312M	338M	330M	288M
Prepaid Expenses	1.79M	2.02M	2.73M	2.69M	3.19M
Other Current Assets, Total	2.33M	2.79M	2.74M	1.51M	1.59M
Total Current Assets	506M	623M	509M	490M	567M
Gross Property Plant And Equipment	369M	422M	481M	532M	597M
Accumulated Depreciation	-187M	-206M	-227M	-245M	-266M
Net Property Plant And Equipment	182M	216M	254M	287M	331M
Long-term Investments	2.07M	2.2M	591K	19.52M	19.16M
Goodwill	-	-	-	-	2.7M
Other Intangibles, Total	31.51M	29.14M	27.74M	28.23M	33.18M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	3.85M	2.08M	2.34M	2.26M	3.2M
Deferred Charges Long-Term	7.04M	6.6M	6.16M	5.72M	-
Other Long-Term Assets, Total	65K	65K	65K	65K	-
Total Assets	733M	879M	800M	832M	956M
Liabilities
Accounts Payable, Total	99.4M	130M	110M	89.93M	84.75M
Accrued Expenses, Total	18.35M	34.35M	30.77M	33.19M	30.23M
Current Portion of Long-Term Debt	2.98M	8.27M	8.06M	17.84M	22.26M
Current Portion of Leases	3.44M	4.46M	5.12M	5.85M	6.36M
Current Income Taxes Payable	681K	-	5.26M	2.38M	4.4M
Unearned Revenue Current, Total	58.12M	115M	39.51M	5.25M	29.64M
Other Current Liabilities	7.42M	973K	1.53M	2.21M	3.58M
Total Current Liabilities	190M	294M	200M	157M	181M
Long-Term Debt	52.52M	46.04M	38.58M	80.5M	83.88M
Long-Term Leases	14.22M	13.4M	13.67M	10.22M	9.33M
Unearned Revenue Non Current	3.79M	3.32M	2.79M	2.75M	5.46M
Deferred Tax Liability Non Current	776K	677K	1.52M	366K	160K
Other Non Current Liabilities	-	-	-	-	191K
Total Liabilities	262M	357M	256M	250M	280M
Common Stock, Total	3.36M	3.24M	3.24M	3.07M	3.07M
Additional Paid In Capital	87.64M	87.64M	87.64M	87.64M	87.64M
Retained Earnings	446M	457M	556M	487M	579M
Treasury Stock	-66.12M	-27.56M	-108M	-5.54M	-5.17M
Comprehensive Income and Other	-2K	-8K	-21K	-23K	-54K
Total Common Equity	471M	520M	539M	572M	664M
Minority Interest	-	1.37M	4.11M	9.51M	11.04M
Total Equity	471M	521M	543M	582M	675M
Total Liabilities And Equity	733M	879M	800M	832M	956M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	54.85M	53.37M	51.82M	51.15M	51.15M
ECS Total Common Shares Outstanding	54.85M	53.37M	51.82M	51.15M	51.15M
Book Value / Share	8.59	9.74	10.41	11.18	12.99
Tangible Book Value	439M	491M	512M	544M	629M
Tangible Book Value Per Share	8.01	9.2	9.87	10.63	12.29
Total Debt	73.16M	72.17M	65.43M	114M	122M
Net Debt	-25.97M	-52.87M	39.99M	86.39M	23.22M
Debt Equivalent Oper. Leases	6.71M	27.76M	19.7M	6.88M	11.06M
Minority Interest, Total (Incl. Fin. Div)	-	1.37M	4.11M	9.51M	11.04M
Equity Method Investments, Total	1.99M	2.19M	567K	19.52M	19.16M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	125M	159M	169M	106M	103M
Inventories - Work In Process, Total	50.45M	78.72M	80.5M	128M	119M
Inventories - Finished Goods, Total	70.09M	74.19M	88.1M	95.35M	66.5M
Land - (BS)	37.25M	45.12M	60.64M	74.8M	81.79M
Machinery, Total	275M	304M	373M	404M	445M
Full Time Employees	1.75K	1.99K	2.11K	1.93K	1.95K
Part Time Employees	-	-	-	67	95
Accumulated Allowance for Doubtful Accounts (Supple)	57K	536K	518K	349K	244K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	153M	200M	170M	137M	140M
Depreciation & Amortization - CF	17.88M	19.39M	21.06M	24.97M	26.99M
Amortization of Goodwill and Intangible Assets - (CF)	2.42M	2.45M	2.37M	1.95M	1.77M
Depreciation & Amortization, Total	20.3M	21.84M	23.44M	26.92M	28.76M
Amortization of Deferred Charges, Total - (CF)	1.06M	1.03M	895K	1.09M	1.62M
(Gain) Loss From Sale Of Asset	-	-	-	4.39M	14K
(Gain) Loss on Sale of Investments - (CF)	-1.16M	-1.83M	219K	-81K	511K
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-182K	-199K	125K	141K	-60K
Stock-Based Compensation (CF)	1.4M	-	-	-	-
Provision and Write-off of Bad Debts	-268K	40K	-38K	-7.97M	-305K
Other Operating Activities, Total	39.24M	74.02M	-47.28M	-32.06M	11.55M
Change In Accounts Receivable	-74.19M	-26.82M	19.47M	13.41M	-30.18M
Change In Inventories	-23.43M	-71.59M	-29.29M	11.87M	42.99M
Change In Accounts Payable	35.36M	41.67M	-23.92M	-16.36M	-7.75M
Change in Other Net Operating Assets	-1.78M	-234K	-702K	40K	-501K
Cash from Operations	149M	238M	113M	138M	187M
Capital Expenditure	-40.22M	-50.72M	-53.79M	-59.12M	-65.21M
Sale of Property, Plant, and Equipment	33K	78K	382K	37K	143K
Sale (Purchase) of Intangible assets	-722K	-669K	-1.39M	-3.1M	-2.6M
Investment in Marketable and Equity Securities, Total	-	-5.85M	1.29M	-19.01M	-3.46M
Other Investing Activities, Total	68K	6K	1.49M	134K	2.66M
Cash from Investing	-40.84M	-57.15M	-52.03M	-81.06M	-68.48M
Long-Term Debt Issued, Total	1.34M	1.4M	734K	96.95M	47.61M
Total Debt Issued	1.34M	1.4M	734K	96.95M	47.61M
Long-Term Debt Repaid, Total	-6.19M	-6.77M	-13.65M	-51.71M	-46.79M
Total Debt Repaid	-6.19M	-6.77M	-13.65M	-51.71M	-46.79M
Issuance of Common Stock	42.33M	77.77M	52.64M	41.92M	54.85M
Repurchase of Common Stock	-78.78M	-177M	-134M	-89.71M	-54.86M
Common Dividends Paid	-21.13M	-51.01M	-69.05M	-56.45M	-47.83M
Common & Preferred Stock Dividends Paid	-21.13M	-51.01M	-69.05M	-56.45M	-47.83M
Other Financing Activities, Total	-288K	1.08M	2.39M	3.64M	-790K
Cash from Financing	-62.73M	-155M	-161M	-55.36M	-47.81M
Net Change in Cash	45.87M	25.91M	-99.62M	1.86M	70.79M
Supplemental Items
Cash Interest Paid	292K	291K	388K	1.77M	2.3M
Cash Income Tax Paid (Refund)	23.86M	43.89M	40.86M	44.23M	41.93M
Levered Free Cash Flow	67.18M	136M	25.36M	44.63M	82.3M
Unlevered Free Cash Flow	67.75M	136M	25.95M	46.09M	83.9M
Change In Net Working Capital	28.78M	-6.38M	80.36M	31.39M	-13.12M
Net Debt Issued / Repaid	-4.85M	-5.37M	-12.92M	45.24M	818K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	17.38	19.68	16.34	13.69	12.11
Return on Total Capital	22.89	27.88	22.81	17.12	14.49
Return On Equity %	36.25	40.24	31.98	24.33	22.33
Return on Common Equity	36.25	40.3	32.16	24.63	22.72
Margin Analysis
Gross Profit Margin %	58.56	62.67	58.27	61.24	63.43
SG&A Margin	15.92	15.9	17.72	20.72	21.58
EBITDA Margin %	30.55	33.18	28.69	26.14	26.3
EBITA Margin %	28.39	31.33	26.74	23.65	23.53
EBIT Margin %	28.02	31.03	26.46	23.4	23.29
Income From Continuing Operations Margin %	23.6	24.42	20.53	17.92	18.88
Net Income Margin %	23.6	24.42	20.53	17.92	18.89
Net Avail. For Common Margin %	23.6	24.42	20.53	17.92	18.89
Normalized Net Income Margin	17.76	19.58	16.61	14.54	15.42
Levered Free Cash Flow Margin	10.36	16.62	3.06	5.84	11.07
Unlevered Free Cash Flow Margin	10.44	16.69	3.13	6.04	11.28
Asset Turnover
Asset Turnover	0.99	1.01	0.99	0.94	0.83
Fixed Assets Turnover	3.85	4.12	3.54	2.83	2.41
Receivables Turnover (Average Receivables)	6.72	5.64	5.83	6.38	5.35
Inventory Turnover (Average Inventory)	1.14	1.1	1.07	0.89	0.88
Short Term Liquidity
Current Ratio	2.66	2.12	2.55	3.13	3.13
Quick Ratio	1.35	1.04	0.83	0.99	1.51
Operating Cash Flow to Current Liabilities	0.78	0.81	0.57	0.88	1.03
Days Sales Outstanding (Average Receivables)	54.34	64.73	62.65	57.36	68.27
Days Outstanding Inventory (Average Inventory)	320.87	333.24	342.64	412.88	414.76
Average Days Payable Outstanding	104.62	112.85	115.46	126.96	138.66
Cash Conversion Cycle (Average Days)	270.59	285.13	289.83	343.28	344.38
Long Term Solvency
Total Debt/Equity	15.53	13.84	12.04	19.67	18.04
Total Debt / Total Capital	13.45	12.16	10.74	16.44	15.28
LT Debt/Equity	14.17	11.4	9.61	15.6	13.8
Long-Term Debt / Total Capital	12.27	10.01	8.58	13.04	11.69
Total Liabilities / Total Assets	35.72	40.66	32.05	30.11	29.32
EBIT / Interest Expense	200.81	298.87	231.51	76.04	67.53
EBITDA / Interest Expense	223.25	324.59	256.23	87.5	78.74
(EBITDA - Capex) / Interest Expense	178.81	264.85	199.49	62.34	53.31
Total Debt / EBITDA	0.36	0.26	0.27	0.56	0.6
Net Debt / EBITDA	-0.13	-0.19	0.16	0.42	0.12
Total Debt / (EBITDA - Capex)	0.45	0.32	0.35	0.78	0.89
Net Debt / (EBITDA - Capex)	-0.16	-0.24	0.21	0.59	0.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	54.46	26.06	1.44	-7.93	-2.65
Gross Profit, 1 Yr. Growth %	60.18	34.91	-5.68	-3.23	0.83
EBITDA, 1 Yr. Growth %	121.13	38.04	-12.28	-16.13	-2.04
EBITA, 1 Yr. Growth %	137.34	40.32	-13.4	-18.57	-3.18
EBIT, 1 Yr. Growth %	142.57	40.85	-13.5	-18.58	-3.11
Earnings From Cont. Operations, 1 Yr. Growth %	150.71	30.43	-14.71	-19.63	2.55
Net Income, 1 Yr. Growth %	150.71	30.44	-14.69	-19.64	2.6
Normalized Net Income, 1 Yr. Growth %	149.14	40.22	-13.95	-19.4	3.2
Diluted EPS Before Extra, 1 Yr. Growth %	150.63	35.14	-14.25	-16.53	2.73
Accounts Receivable, 1 Yr. Growth %	104.94	23.44	-22.27	-7.81	42.23
Inventory, 1 Yr. Growth %	8.04	27.08	8.34	-2.37	-12.72
Net Property, Plant and Equip., 1 Yr. Growth %	16.98	18.58	17.68	13	15.39
Total Assets, 1 Yr. Growth %	27.55	19.93	-8.97	4.02	14.86
Tangible Book Value, 1 Yr. Growth %	29.34	11.7	4.23	6.28	16.81
Common Equity, 1 Yr. Growth %	26.03	10.41	3.73	6.05	16.15
Cash From Operations, 1 Yr. Growth %	218.8	58.99	-52.34	22.1	35.29
Capital Expenditures, 1 Yr. Growth %	2.24	26.11	6.06	9.9	10.3
Levered Free Cash Flow, 1 Yr. Growth %	-657.51	105.33	-81.34	75.96	83.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-695.3	104.38	-80.98	77.6	82.02
Dividend Per Share, 1 Yr. Growth %	150.68	35.39	-14.69	-15.28	2.6
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	30.43	39.54	13.08	-3.36	-5.33
Gross Profit, 2 Yr. CAGR %	34.03	47	12.81	-4.46	-1.22
EBITDA, 2 Yr. CAGR %	89.05	74.01	10.04	-14.23	-9.36
EBITA, 2 Yr. CAGR %	103.03	81.71	10.23	-16.03	-11.21
EBIT, 2 Yr. CAGR %	107.93	84.03	10.37	-16.08	-11.18
Earnings From Cont. Operations, 2 Yr. CAGR %	97.43	80.84	5.48	-17.2	-9.21
Net Income, 2 Yr. CAGR %	97.43	80.84	5.49	-17.2	-9.2
Normalized Net Income, 2 Yr. CAGR %	108.93	86.1	9.84	-16.72	-8.8
Diluted EPS Before Extra, 2 Yr. CAGR %	97.03	83.94	7.71	-15.4	-7.4
Accounts Receivable, 2 Yr. CAGR %	34.58	59.05	-2.04	-15.34	14.51
Inventory, 2 Yr. CAGR %	24.33	17.18	17.34	2.85	-7.69
Net Property, Plant and Equip., 2 Yr. CAGR %	17.52	17.77	18.13	15.32	14.19
Total Assets, 2 Yr. CAGR %	19.72	23.68	4.49	-2.69	9.31
Tangible Book Value, 2 Yr. CAGR %	24.12	20.2	7.9	5.25	10.84
Common Equity, 2 Yr. CAGR %	20.87	17.96	7.02	4.88	10.99
Cash From Operations, 2 Yr. CAGR %	306.49	125.14	-12.95	-23.71	28.53
Capital Expenditures, 2 Yr. CAGR %	24.61	13.55	15.65	7.96	10.1
Levered Free Cash Flow, 2 Yr. CAGR %	2.24	235.84	-38.1	-42.7	80.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	3	246.26	-37.65	-41.88	79.8
Dividend Per Share, 2 Yr. CAGR %	133.61	84.23	7.47	-14.99	-6.77
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	28.85	28.95	25.47	5.59	-3.12
Gross Profit, 3 Yr. CAGR %	30.46	34.32	26.79	7.18	-2.73
EBITDA, 3 Yr. CAGR %	94.37	69.78	38.49	0.52	-10.34
EBITA, 3 Yr. CAGR %	119.4	78.99	41.93	-0.35	-11.95
EBIT, 3 Yr. CAGR %	125.39	82.08	43.09	-0.27	-11.96
Earnings From Cont. Operations, 3 Yr. CAGR %	104.52	71.95	40.76	-3.66	-11.08
Net Income, 3 Yr. CAGR %	104.52	71.95	40.77	-3.66	-11.07
Normalized Net Income, 3 Yr. CAGR %	122.73	82.4	43.91	-0.93	-10.55
Diluted EPS Before Extra, 3 Yr. CAGR %	99.24	73.7	42.68	-1.06	-9.74
Accounts Receivable, 3 Yr. CAGR %	36.53	30.76	25.28	-4	0.64
Inventory, 3 Yr. CAGR %	37.29	25.24	14.15	10.36	-2.63
Net Property, Plant and Equip., 3 Yr. CAGR %	23.78	17.87	17.74	16.39	15.34
Total Assets, 3 Yr. CAGR %	22.08	19.79	11.67	4.33	2.84
Tangible Book Value, 3 Yr. CAGR %	18.94	19.84	14.62	7.36	8.59
Common Equity, 3 Yr. CAGR %	17.89	17.28	13.01	6.69	8.51
Cash From Operations, 3 Yr. CAGR %	159.71	197.28	34.18	-2.55	-7.66
Capital Expenditures, 3 Yr. CAGR %	34.88	25.11	11	13.7	8.74
Levered Free Cash Flow, 3 Yr. CAGR %	42.77	28.36	28.15	-12.32	-15.4
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.1	28.8	31.63	-11.62	-14.97
Dividend Per Share, 3 Yr. CAGR %	128.78	94.77	42.53	-0.72	-9.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	19.59	24.29	22.3	14.9	12.1
Gross Profit, 5 Yr. CAGR %	20.45	25.92	23.09	17.21	14.74
EBITDA, 5 Yr. CAGR %	43.45	60.57	54.56	29.2	16.89
EBITA, 5 Yr. CAGR %	50.3	72.55	66.31	32.24	17.65
EBIT, 5 Yr. CAGR %	51.54	75.64	69.1	33.57	18.24
Earnings From Cont. Operations, 5 Yr. CAGR %	42.46	63.21	56.93	28.36	18.11
Net Income, 5 Yr. CAGR %	42.46	63.21	56.93	28.37	18.13
Normalized Net Income, 5 Yr. CAGR %	50.48	71	67.58	33.3	19.91
Diluted EPS Before Extra, 5 Yr. CAGR %	39.17	60.55	55.75	30.3	20.02
Accounts Receivable, 5 Yr. CAGR %	23.42	31.26	19.55	9.89	20.86
Inventory, 5 Yr. CAGR %	29.51	32.81	28.93	15.75	4.86
Net Property, Plant and Equip., 5 Yr. CAGR %	17.02	19.34	21.49	16.84	16.31
Total Assets, 5 Yr. CAGR %	20.55	24.11	14.71	10.23	10.72
Tangible Book Value, 5 Yr. CAGR %	21.97	23.19	14.39	13.77	13.09
Common Equity, 5 Yr. CAGR %	20.76	22.09	13.41	12.15	12.2
Cash From Operations, 5 Yr. CAGR %	26.84	67.47	67.73	72.54	31.89
Capital Expenditures, 5 Yr. CAGR %	32.96	27.71	26.83	17.95	10.64
Levered Free Cash Flow, 5 Yr. CAGR %	27.31	76.97	1.9	-7.03	46.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.8	80.12	2.77	-6.31	49.11
Dividend Per Share, 5 Yr. CAGR %	39.18	60.71	69.11	39.8	20.27